Literature DB >> 20133811

Generation of a novel transgenic mouse model for bioluminescent monitoring of survivin gene activity in vivo at various pathophysiological processes: survivin expression overlaps with stem cell markers.

Fengzhi Li1, Qiuying Cheng, Xiang Ling, Aimee Stablewski, Lei Tang, Barbara A Foster, Candace S Johnson, Youcef M Rustum, Carl W Porter.   

Abstract

Survival has been implicated to play an important role in various pathophysiological processes. However, because of a lack of appropriate animal models, the role and dynamic expression of survivin during pathophysiology are not well defined. We generated a human survivin gene promoter-driven luciferase transgenic mouse model (SPlucTg) so that dynamic survivin gene activity can be monitored during various pathophysiological conditions using in vivo imaging. Our results show that, consistent with survivin positivity in testis, luciferase activity in normal SPlucTg mice was detected in the testis of male mice. Furthermore, similar to the known requirement of transient expression of survivin for pathophysiological responses, we observed a transient luciferase expression in castrated SPlucTg male mice after supplement of androgen. Significantly, it was reported that survivin expression turns on during mouse liver injury and regeneration; a transient and dose-dependent luciferase expression in the mouse liver was observed after administration of carbon tetrachloride into SPlucTg mice. We further demonstrated that luciferase activity closely correlates with endogenous survivin expression. We also demonstrated that only a subset of cells expresses survivin, and its expression overlaps with the expression of several stem cell markers tested. Thus, we have generated a unique animal model for analysis of diverse pathophysiological processes and possible stem cell distribution/activity in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133811      PMCID: PMC2843455          DOI: 10.2353/ajpath.2010.090414

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  69 in total

1.  Transcriptional analysis of human survivin gene expression.

Authors:  F Li; D C Altieri
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

2.  Transcriptional repression of the anti-apoptotic survivin gene by wild type p53.

Authors:  William H Hoffman; Siham Biade; Jack T Zilfou; Jiandong Chen; Maureen Murphy
Journal:  J Biol Chem       Date:  2001-11-19       Impact factor: 5.157

3.  Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer.

Authors:  T Zhang; T Otevrel; Z Gao; Z Gao; S M Ehrlich; J Z Fields; B M Boman
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

4.  Survivin expression in the bone marrow of patients with severe congenital neutropenia.

Authors:  G Carlsson; S Boxhammer; D Garwicz; J I Henter; J Palmblad; M Nordenskjöld; A Porwit; B Fadeel
Journal:  Leukemia       Date:  2008-09-25       Impact factor: 11.528

5.  Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis.

Authors:  S Fukuda; L M Pelus
Journal:  Blood       Date:  2001-10-01       Impact factor: 22.113

6.  Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin.

Authors:  D S O'Connor; D Grossman; J Plescia; F Li; H Zhang; A Villa; S Tognin; P C Marchisio; D C Altieri
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

7.  Cancer gene therapy using a survivin mutant adenovirus.

Authors:  M Mesri; N R Wall; J Li; R W Kim; D C Altieri
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

8.  Every single cell clones from cancer cell lines growing tumors in vivo may not invalidate the cancer stem cell concept.

Authors:  Fengzhi Li
Journal:  Mol Cells       Date:  2009-04-13       Impact factor: 5.034

9.  The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner.

Authors:  J Zhao; T Tenev; L M Martins; J Downward; N R Lemoine
Journal:  J Cell Sci       Date:  2000-12       Impact factor: 5.285

10.  The 'stem cell' concept: is it holding us back?

Authors:  Arthur D Lander
Journal:  J Biol       Date:  2009-09-21
View more
  15 in total

1.  Expression of Wnt9, TCTP, and Bmp1/Tll in sea cucumber visceral regeneration.

Authors:  Vladimir S Mashanov; Olga R Zueva; Jose E Garcia-Arraras
Journal:  Gene Expr Patterns       Date:  2011-11-04       Impact factor: 1.224

2.  Suppression of survivin promoter activity by YM155 involves disruption of Sp1-DNA interaction in the survivin core promoter.

Authors:  Qiuying Cheng; Xiang Ling; Andrew Haller; Takahito Nakahara; Kentaro Yamanaka; Aya Kita; Hiroshi Koutoku; Masahiro Takeuchi; Michael G Brattain; Fengzhi Li
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

Review 3.  Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?

Authors:  Fengzhi Li; Tao Jiang; Qingyong Li; Xiang Ling
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

Review 4.  Hepatic stem cell niches.

Authors:  Claus Kordes; Dieter Häussinger
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

5.  Developmental control of apoptosis by the immunophilin aryl hydrocarbon receptor-interacting protein (AIP) involves mitochondrial import of the survivin protein.

Authors:  Byoung Heon Kang; Fang Xia; Ramona Pop; Takehiko Dohi; Merav Socolovsky; Dario C Altieri
Journal:  J Biol Chem       Date:  2011-03-18       Impact factor: 5.157

Review 6.  Survivin and IAP proteins in cell-death mechanisms.

Authors:  Dario C Altieri
Journal:  Biochem J       Date:  2010-09-01       Impact factor: 3.857

7.  Transcription factor TCF4 maintains the properties of human corneal epithelial stem cells.

Authors:  Rong Lu; Yangluowa Qu; Jian Ge; Lili Zhang; Zhitao Su; Stephen C Pflugfelder; De-Quan Li
Journal:  Stem Cells       Date:  2012-04       Impact factor: 6.277

Review 8.  Illuminating cancer systems with genetically engineered mouse models and coupled luciferase reporters in vivo.

Authors:  Brandon Kocher; David Piwnica-Worms
Journal:  Cancer Discov       Date:  2013-04-12       Impact factor: 39.397

9.  The Synthetic Triterpenoid RTA 405 (CDDO-EA) Halts Progression of Liver Fibrosis and Reduces Hepatocellular Carcinoma Size Resulting in Increased Survival in an Experimental Model of Chronic Liver Injury.

Authors:  Yonas Getachew; Frank A Cusimano; Purva Gopal; Scott A Reisman; Jerry W Shay
Journal:  Toxicol Sci       Date:  2015-10-05       Impact factor: 4.849

10.  Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types.

Authors:  Xiang Ling; Diane Calinski; Asher A Chanan-Khan; Muxiang Zhou; Fengzhi Li
Journal:  J Exp Clin Cancer Res       Date:  2010-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.